IFNL2 and infection: Nasal administration of B. longum resulted in its presence in the lungs for up to 36 h (Figure 5F), with significantly lower virus titer in the lungs and higher IFN-λ2,3 expression level on day 2 post-infection, compared with the control (Figures 5G and 5H).